|Videos|February 18, 2021
New Deterrent Stimulants for ADHD
Author(s)Timothy Wilens, MD
What observations are being noted in the field with new agents for the treatment of ADHD?
Advertisement
Timothy Wilens, MD, talks about the presentation of the APSARD 2021 conference on ADAIR Pharmacokinetics and Pharmacodynamic Data. More on the presentation can be found
Dr Wilens is chief of the Division of Child and Adolescent Psychiatry and is co-director of the Center for Addiction Medicine at Massachusetts General Hospital.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Psychedelic PSX-001 for Generalized Anxiety Disorder: A Conversation With Lou Barbato, MD
2
The Concept of Mental Illness, and Why the DSM Approach Is Wrong
3
Antidepressants Assessed for Reducing Negative Symptoms of Schizophrenia
4
Favorable Profile Data On MK-2214 for Treatment of Alzheimer Disease
5
